Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.

Authors:
Enomoto H; Ueno Y; Hiasa Y; Nishikawa H; Hige S and 11 more

Journal:
J Gastroenterol

Publication Year: 2019

DOI:
10.1007/s00535-019-01645-y

PMCID:
PMC7026312

PMID:
31768801

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Gastroenterol

Abbreviation: J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of p…
Kashiro A; Kobayashi M; Oh T and 23 more (2024) - Transparency Score: 3/6
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis.
Leech T; Peiris M. (2024) - Transparency Score: 3/6
Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan…
Sasaki K; Kawai K; Nozawa H and 17 more (2024) - Transparency Score: 4/6
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19…
Nakase H; Wagatsuma K; Nojima M and 31 more (2023) - Transparency Score: 4/6
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating…
Jiang K; Lu S; Li D and 7 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest Yoshiyuki Ueno received honoraria from AbbVie and EA-Pharma. Koichi Takaguchi has received honoraria from AbbVie. Masaki Kurosaki received honoraria from Gilead, AbbVie, Bayer, Otsuka and Eisai. Tatsuya Kanto received honoraria from MSD and Gilead. Shuhei Nishiguchi received honoraria from AbbVie and Gilead and research grants from AbbVie, Toray and EA-Pharma. The other authors have no conflicts of interest to disclose."

Evidence found in paper:

"Funding No financial support."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025